TNX-1500
2025P-------
Phase 2 small_molecule active
Quick answer
TNX-1500 for Kidney Transplant is a Phase 2 program (small_molecule) at Tonix Pharmaceuticals Holding with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tonix Pharmaceuticals Holding
- Indication
- Kidney Transplant
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active